189 related articles for article (PubMed ID: 38068723)
1. Probiotic
Han S; Wang K; Shen J; Xia H; Lu Y; Zhuge A; Li S; Qiu B; Zhang S; Dong X; Yao M; Li L
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068723
[TBL] [Abstract][Full Text] [Related]
2. Pediococcus pentosaceus LI05 alleviates DSS-induced colitis by modulating immunological profiles, the gut microbiota and short-chain fatty acid levels in a mouse model.
Bian X; Yang L; Wu W; Lv L; Jiang X; Wang Q; Wu J; Li Y; Ye J; Fang D; Shi D; Wang K; Wang Q; Lu Y; Xie J; Xia J; Li L
Microb Biotechnol; 2020 Jul; 13(4):1228-1244. PubMed ID: 32363766
[TBL] [Abstract][Full Text] [Related]
3. Effects of Pediococcus pentosaceus LI05 on immunity and metabolism in germ-free rats.
Jiang S; Xia J; Lv L; Wang Q; Li Y; Xu Q; Bian X; Ye J; Yang L; Jiang H; Yan R; Wang K; Fang D; Li L
Food Funct; 2021 Jun; 12(11):5077-5086. PubMed ID: 33960989
[TBL] [Abstract][Full Text] [Related]
4. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl
Shi D; Lv L; Fang D; Wu W; Hu C; Xu L; Chen Y; Guo J; Hu X; Li A; Guo F; Ye J; Li Y; Andayani D; Li L
Sci Rep; 2017 Jul; 7(1):6927. PubMed ID: 28761060
[TBL] [Abstract][Full Text] [Related]
5. Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling.
Meadows V; Kennedy L; Ekser B; Kyritsi K; Kundu D; Zhou T; Chen L; Pham L; Wu N; Demieville J; Hargrove L; Glaser S; Alpini G; Francis H
Hepatology; 2021 Nov; 74(5):2684-2698. PubMed ID: 34164827
[TBL] [Abstract][Full Text] [Related]
6. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
[TBL] [Abstract][Full Text] [Related]
7. Targeting FXR in Cholestasis.
Keitel V; Dröge C; Häussinger D
Handb Exp Pharmacol; 2019; 256():299-324. PubMed ID: 31201556
[TBL] [Abstract][Full Text] [Related]
8. Melatonin improves cholestatic liver disease via the gut-liver axis.
Liu X; Li J; Shi M; Fu J; Wang Y; Kang W; Liu J; Zhu F; Huang K; Chen X; Liu Y
J Pineal Res; 2024 Jan; 76(1):e12929. PubMed ID: 38047407
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
[TBL] [Abstract][Full Text] [Related]
10. Protective Effect of
Xu Q; Gu S; Chen Y; Quan J; Lv L; Chen D; Zheng B; Xu L; Li L
Front Microbiol; 2018; 9():2396. PubMed ID: 30356740
[No Abstract] [Full Text] [Related]
11. Protective effect of
Wu Y; Li S; Lv L; Jiang S; Xu L; Chen H; Li L
Food Funct; 2024 Apr; 15(7):3692-3708. PubMed ID: 38488110
[No Abstract] [Full Text] [Related]
12. Prevotella copri ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway.
Jiang B; Yuan G; Wu J; Wu Q; Li L; Jiang P
Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166320. PubMed ID: 34896545
[TBL] [Abstract][Full Text] [Related]
13. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
[TBL] [Abstract][Full Text] [Related]
14. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
[TBL] [Abstract][Full Text] [Related]
15. Impact of encapsulating a probiotic (Pediococcus pentosaceus Li05) within gastro-responsive microgels on Clostridium difficile infections.
Xie J; Yao M; Lu Y; Yu M; Han S; McClements DJ; Xiao H; Li L
Food Funct; 2021 Apr; 12(7):3180-3190. PubMed ID: 33734244
[TBL] [Abstract][Full Text] [Related]
16. Yinchen decoction protects against cholic acid diet-induced cholestatic liver injury in mice through liver and ileal FXR signaling.
Song G; Zou B; Zhao J; Weng F; Li Y; Xu X; Zhang S; Yan D; Jin J; Sun X; Liu C; Qiu F
J Ethnopharmacol; 2023 Sep; 313():116560. PubMed ID: 37149065
[TBL] [Abstract][Full Text] [Related]
17. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
[TBL] [Abstract][Full Text] [Related]
18. Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis.
Milkiewicz M; Klak M; Kempinska-Podhorodecka A; Wiechowska-Kozlowska A; Urasinska E; Blatkiewicz M; Wunsch E; Elias E; Milkiewicz P
Sci Rep; 2016 Dec; 6():39573. PubMed ID: 28008998
[TBL] [Abstract][Full Text] [Related]
19. Whole-genome sequence assembly of Pediococcus pentosaceus LI05 (CGMCC 7049) from the human gastrointestinal tract and comparative analysis with representative sequences from three food-borne strains.
Lv LX; Li YD; Hu XJ; Shi HY; Li LJ
Gut Pathog; 2014; 6():36. PubMed ID: 25349631
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the
Fuchs CD; Sroda N; Scharnagl H; Gupta R; Minto W; Stojakovic T; Liles JT; Budas G; Hollenback D; Trauner M
JHEP Rep; 2023 Nov; 5(11):100874. PubMed ID: 37841639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
